(Q39339080)

11 September 2017

Activation of the damage-associated molecular pattern receptor P2X7 induces interleukin-1β release from canine monocytes (English)

1 reference

11 September 2017

0 references

Iman Jalilian

1

1 reference

11 September 2017

Michelle Peranec

2

1 reference

11 September 2017

Belinda L Curtis

3

1 reference

11 September 2017

Aine Seavers

4

1 reference

11 September 2017

Mari Spildrejorde

5

1 reference

11 September 2017

Vanessa Sluyter

6

1 reference

11 September 2017

Ronald Sluyter

7

1 reference

11 September 2017

language of work or name

1 reference

8 May 2012

1 reference

Veterinary Immunology and Immunopathology

11 September 2017

1 reference

11 September 2017

149

1 reference

11 September 2017

1-2

1 reference

11 September 2017

86-91

1 reference

Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X(7) receptor

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Pharmacological properties of the rhesus macaque monkey P2X7 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Sterile inflammation: sensing and reacting to damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

P2X7 receptor activation induces cell death and microparticle release in murine erythroleukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Liaisons dangereuses: P2X(7) and the inflammasome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

TGF-β1 prevents up-regulation of the P2X7 receptor by IFN-γ and LPS in leukemic THP-1 monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

The role of P2X₇ in pain and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

ATP-gated P2X cation-channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

How dying cells alert the immune system to danger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Expression profiling of select cytokines in canine osteoarthritis tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Cloning and pharmacological characterization of the dog P2X7 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Inhibition of the human P2X7 receptor by a novel protein tyrosine kinase antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Canine erythrocytes express the P2X7 receptor: greatly increased function compared with human erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

Significance of P2X7 receptor variants to human health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

The P2X(7) receptor mediates the uptake of organic cations in canine erythrocytes and mononuclear leukocytes: comparison to equivalent human cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

The human P2X7 receptor and its role in innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.004

10.1016/J.VETIMM.2012.05.004

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference